54 research outputs found
IntelliGraphs: Datasets for Benchmarking Knowledge Graph Generation
Knowledge Graph Embedding (KGE) models are used to learn continuous
representations of entities and relations. A key task in the literature is
predicting missing links between entities. However, Knowledge Graphs are not
just sets of links but also have semantics underlying their structure.
Semantics is crucial in several downstream tasks, such as query answering or
reasoning. We introduce the subgraph inference task, where a model has to
generate likely and semantically valid subgraphs. We propose IntelliGraphs, a
set of five new Knowledge Graph datasets. The IntelliGraphs datasets contain
subgraphs with semantics expressed in logical rules for evaluating subgraph
inference. We also present the dataset generator that produced the synthetic
datasets. We designed four novel baseline models, which include three models
based on traditional KGEs. We evaluate their expressiveness and show that these
models cannot capture the semantics. We believe this benchmark will encourage
the development of machine learning models that emphasize semantic
understanding
Enhanced expression of fibroblast growth factors and receptor FGFR-1 during vascular remodeling in chronic obstructive pulmonary disease
Important characteristics of chronic obstructive pulmonary disease (COPD)
include airway and vascular remodeling, the molecular mechanisms of which
are poorly understood. We assessed the role of fibroblast growth factors
(FGF) in pulmonary vascular remodeling by examining the expression pattern
of FGF-1, FGF-2, and the FGF receptor (FGFR-1) in peripheral area of lung
tissues from patients with COPD (FEV(1) < or = 75%; n = 15) and without
COPD (FEV(1) > or = 85%; n = 13). Immunohistochemical staining results
were evaluated by digital video image analysis as well as by manual
scoring. FGF-1 and FGFR-1 were detected in vascular smooth muscle (VSM),
airway smooth muscle, and airway epithelial cells. FGF-2 was localized in
the cytoplasm of airway epithelium and in the nuclei of airway smooth
muscle, VSM, and endothelial cells. In COPD cases, an unequivocal increase
in FGF-2 expression was observed in VSM (3-fold, P = 0.001) and
endothelium (2-fold, P = 0.007) of small pulmonary vessels with a luminal
diameter under 200 micro m. In addition, FGFR-1 levels were elevated in
the intima (1.5-fold, P = 0.05). VSM cells of large (> 200 micro m)
pulmonary vessels showed increased staining for FGF-1 (1.6-fold, P < 0.03)
and FGFR-1 (1.4-fold, P < 0.04) in COPD. Pulmonary vascular remodeling,
assessed as the ratio of alpha-smooth muscle actin staining and vascular
wall area with the lumen diameter, was increased in large vessels of
patients with COPD (P = 0.007) and was inversely correlated with FEV(1)
values (P < 0.007). Our results suggest an autocrine role of the
FGF-FGFR-1 system in the pathogenesis of COPD-associated vascular
remodeling
The Romanian Journal of European Studies No.4/2005
The Romanian Journal of European Studies No.4/2005
ISSN 1583 - 199X
EUV - Editura Universitatii de Vest, Timisoara, 2005
The British Coucil in Bucharest and The School of High Comparative European Studies (SISEC), within the West University of Timisoara, edited The Romanian Journal of European Studies - special issue on migration and mobility (Guest editor: Mr. Martin GEIGER, Bonn University, Germany; contact: [email protected]). For more information or to obtain a printed copy, please contact Mr. Dan MOGA, at SISEC (E-mail: [email protected])
CONTENTS:
Foreword; Grigore Silasi ... page 5
Editorial; Martin Geiger ... pages 7 - 8
Forms and Features of the Post-Enlargement Migration Space; Paolo Ruspini ... pages 9 - 18
Managing Migration for an Enlarging Europe - Inter-governmental Organizations and the Governance of the Migration Flows; Martin Geiger ... pages 19 - 30
Balkan Migrations and The European Union: Patterns and Trends; Martin Baldwin-Edwards ... pages 31 - 43
Workers' Mobility': Europe's Integration and Second Thoughts; Peter van Krieken ... pages 45 - 53
Romania's External Migration in the Context of Accesion to the EU: Mechanisms, Institutions and Social-Cultural Issues; Luminita Nicolescu, Daniela-Luminita Constantin ... pages 55 - 63
Migrations et incidence sur la répartition spatiale de la population en Roumanie au niveau national et régional; Vasile Ghetau ... pages 65 - 8
Confirmation of a metastasis-specific microRNA signature in primary colon cancer
The identification of patients with high-risk stage II colon cancer who may benefit from adjuvant therapy may allow the clinical approach to be tailored for these patients based on an understanding of tumour biology. MicroRNAs have been proposed as markers of the prognosis or treatment response in colorectal cancer. Recently, a 2-microRNA signature (l et-7i and miR-10b) was proposed to identify colorectal cancer patients at risk of developing distant metastasis. We assessed the prognostic value of this signature and additional candidate microRNAs in an independent, clinically well-defined, prospectively collected cohort of primary colon cancer patients including stage I-II colon cancer without and stage III colon cancer with adjuvant treatment. The 2-microRNA signature specifically predicted hepatic recurrence in the stage I-II group, but not the overall ability to develop distant metastasis. The addition of miR-30b to the 2-microRNA signature allowed the prediction of both distant metastasis and hepatic recurrence in patients with stage I-II colon cancer who did not receive adjuvant chemotherapy. Available gene expression data allowed us to associate m iR-30b expression with axon guidance and l et-7i expression with cell adhesion, migration, and motility
Improving calculation, interpretation and communication of familial colorectal cancer risk: Protocol for a randomized controlled trial
Contains fulltext :
88114.pdf (publisher's version ) (Open Access)BACKGROUND: Individuals with multiple relatives with colorectal cancer (CRC) and/or a relative with early-onset CRC have an increased risk of developing CRC. They are eligible for preventive measures, such as surveillance by regular colonoscopy and/or genetic counselling. Currently, most at-risk individuals do not follow the indicated follow-up policy. In a new guideline on familial and hereditary CRC, clinicians have new tasks in calculating, interpreting, and communicating familial CRC risk. This will lead to better recognition of individuals at an increased familial CRC risk, enabling them to take effective preventive measures. This trial compares two implementation strategies (a common versus an intensive implementation strategy), focussing on clinicians' risk calculation, interpretation, and communication, as well as patients' uptake of the indicated follow-up policy. METHODS: A clustered randomized controlled trial including an effect, process, and cost evaluation will be conducted in eighteen hospitals. Nine hospitals in the control group will receive the common implementation strategy (i.e., dissemination of the guideline). In the intervention group, an intensive implementation strategy will be introduced. Clinicians will receive education and tools for risk calculation, interpretation, and communication. Patients will also receive these tools, in addition to patient decision aids. The effect evaluation includes assessment of the number of patients for whom risk calculation, interpretation, and communication is performed correctly, and the number of patients following the indicated follow-up policy. The actual exposure to the implementation strategies and users' experiences will be assessed in the process evaluation. In a cost evaluation, the costs of the implementation strategies will be determined. DISCUSSION: The results of this study will help determine the most effective method as well as the costs of improving the recognition of individuals at an increased familial CRC risk. It will provide insight into the experiences of both patients and clinicians with these strategies.The knowledge gathered in this study can be used to improve the recognition of familial and hereditary CRC at both the national and international level, and will serve as an example to improve care for patients and their relatives worldwide. Our results may also be useful in improving healthcare in other diseases. TRIAL REGISTRATION: ClinicalTrials.gov NCT00929097
EURECCA colorectal: multidisciplinary mission statement on better care for patients with colon and rectal cancer in Europe
Background: Care for patients with colon and rectal cancer has improved in the last twenty years however still considerable variation exists in cancer management and outcome between European countries. Therefore, EURECCA, which is the acronym of European Registration of cancer care, is aiming at defining core treatment strategies and developing a European audit structure in order to improve the quality of care for all patients with colon and rectal cancer. In December 2012 the first multidisciplinary consensus conference about colon and rectum was held looking for multidisciplinary consensus. The expert panel consisted of representatives of European scientific organisations involved in cancer care of patients with colon and rectal cancer and representatives of national colorectal registries. Methods: The expert panel had delegates of the European Society of Surgical Oncology (ESSO), European Society for Radiotherapy & Oncology (ESTRO), European Society of Pathology (ESP), European Society for Medical Oncology (ESMO), European Society of Radiology (ESR), European Society of Coloproctology (ESCP), European CanCer Organisation (ECCO), European Oncology Nursing Society (EONS) and the European Colorectal Cancer Patient Organisation (EuropaColon), as well as delegates from national registries or audits. Experts commented and voted on the two web-based online voting rounds before the meeting (between 4th and 25th October and between the 20th November and 3rd December 2012) as well as one online round after the meeting (4th-20th March 2013) and were invited to lecture on the subjects during the meeting (13th-15th December 2012). The sentences in the consensus document were available during the meeting and a televoting round during the conference by all participants was performed. All sentences that were voted on are available on the EURECCA website www.canceraudit.eu. The consensus document was divided in sections describing evidence based algorithms of diagnostics, pathology, surgery, medical oncology, radiotherapy, and follow-up where applicable for treatment of colon cancer, rectal cancer and stage IV separately. Consensus was achieved using the Delphi method. Results: The total number of the voted sentences was 465. All chapters were voted on by at least 75% of the experts. Of the 465 sentences, 84% achieved large consensus, 6% achieved moderate consensus, and 7% resulted in minimum consensus. Only 3% was disagreed by more than 50% of the members. Conclusions: It is feasible to achieve European Consensus on key diagnostic and treatment issues using the Delphi method. This consensus embodies the expertise of professionals from all disciplines involved in the care for patients with colon and rectal cancer. Diagnostic and treatment algorithms were developed to implement the current evidence and to define core treatment guidance for multidisciplinary team management of colon and rectal cancer throughout Europe
Clinical impact of HLA class I expression in rectal cancer
Contains fulltext :
69499.pdf (publisher's version ) (Open Access)PURPOSE: To determine the clinical impact of human leukocyte antigen (HLA) class I expression in irradiated and non-irradiated rectal carcinomas. EXPERIMENTAL DESIGN: Tumor samples in tissue micro array format were collected from 1,135 patients. HLA class I expression was assessed after immunohistochemical staining with two antibodies (HCA2 and HC10). RESULTS: Tumors were split into two groups: (1) tumors with >50% of tumor cells expressing HLA class I (high) and (2) tumors with < or =50% of tumor cells expressing HLA class I (low). No difference in distribution or prognosis of HLA class I expression was found between irradiated and non-irradiated patients. Patients with low expression of HLA class I (15% of all patients) showed an independent significantly worse prognosis with regard to overall survival and disease-free survival. HLA class I expression had no effect on cancer-specific survival or recurrence-free survival. CONCLUSIONS: Down-regulation of HLA class I in rectal cancer is associated with poor prognosis. In contrast to our results, previous reports on HLA class I expression in colorectal cancer described a large population of patients with HLA class I negative tumors, having a good prognosis. This difference might be explained by the fact that a large proportion of HLA negative colon tumors are microsatellite instable (MSI). MSI tumors are associated with a better prognosis than microsatellite stable (MSS). As rectal tumors are mainly MSS, our results suggest that it is both, oncogenic pathway and HLA class I expression, that dictates patient's prognosis in colorectal cancer. Therefore, to prevent confounding in future prognostic analysis on the impact of HLA expression in colorectal tumors, separate analysis of MSI and MSS tumors should be performed
Ki-67 as a prognostic marker in mantle cell lymphoma—consensus guidelines of the pathology panel of the European MCL Network
Mantle cell lymphoma (MCL) has a heterogeneous clinical course and is mainly an aggressive B cell non-Hodgkin lymphoma; however, there are some indolent cases The Ki-67 index, defined by the percentage of Ki-67-positive lymphoma cells on histopathological slides, has been shown to be a very powerful prognostic biomarker. The pathology panel of the European MCL Network evaluated methods to assess the Ki-67 index including stringent counting, digital image analysis, and estimation by eyeballing. Counting of 2 × 500 lymphoma cells is the gold standard to assess the Ki-67 index since this value has been shown to predict survival in prospective randomized trials of the European MCL Network. Estimation by eyeballing and digital image analysis showed a poor concordance with the gold standard (concordance correlation coefficients [CCC] between 0.29 and 0.61 for eyeballing and CCC of 0.24 and 0.37 for two methods of digital image analysis, respectively). Counting a reduced number of lymphoma cells (2 × 100 cells) showed high interobserver agreement (CCC = 0.74). Pitfalls of the Ki-67 index are discussed and guidelines and recommendations for assessing the Ki-67 index in MCL are given
The Emergence and Development of Association Football: Influential Sociocultural Factors in Victorian Birmingham
This article explores the interdependent, complex sociocultural factors that facilitated the emergence and diffusion of football in Birmingham. The focus is the development of football in the city, against the backdrop of the numerous social changes in Victorian Birmingham. The aim is to fill a gap in the existing literature which seemingly overlooked Birmingham as a significant footballing centre, and the ‘ordinary and everyday’ aspects of the game’s early progression. Among other aspects, particular heed is paid to the working classes’ involvement in football, as previous literature has often focused on the middle classes and their influence on and participation in organized sport. As the agency of the working classes along with their mass participation and central role in the game’s development is unfolded, it is argued that far from being passive cultural beings, the working classes, from the beginnings, actively negotiated the development of their own emergent football culture
- …